Search inside eBookDB


Author: A. Bruce Steinwald
Publisher: DIANE Publishing
Keywords: subsidy, income, manufacturer, state, drug, uneven, access, programs, important, part, low, assets, medicare, denials
Number of Pages: 39
Published: 2009-02
ISBN-10: 1437909647
ISBN-13: 9781437909647

To help defray the cost of prescription drugs for beneficiaries with limited means, the Medicare Prescription, Improvement, and Modernization Act of 2003 included the low-income subsidy (LIS) in the Part D prescription drug insurance program. To qualify for the LIS, beneficiaries must be enrolled in a Part D plan and their assets and income must be less than the thresholds established by the law. This report focuses on beneficiaries¿ access to prescription drugs by examining: (1) the importance of assets and income in LIS denials in 2006 and 2007; and (2) state and manufacturer programs provi
10553

Author: Jennifer R. Luong
Publisher: DIANE Publishing
Keywords: reported, price, concessions, data, oversight, federal, part, prescription, drug, coverage, medicare
Number of Pages: 16
Published: 2010-03
ISBN-10: 1437911471
ISBN-13: 9781437911473

The outpatient prescription drug benefit known as Medicare Part D was first available in Jan. 2006, and that year it provided federally subsidized prescription drug coverage for nearly 28 million beneficiaries at a cost of $47.4 billion -- almost 12% of total Medicare spending. Part D sponsors -- entities that enter into contracts with Medicare -- administer the benefit and compete for beneficiary enrollment. To provide coverage, the sponsors enter into contractual relationships with pharmacy benefit managers, drug manufacturers, and retail pharmacies. The Part D program relies on sponsors to
1978

Author: John E. Dicken
Publisher: DIANE Publishing
Keywords: drugs, commonly, used, prices, customary, trends, prescription
Number of Pages: 28
Published: 2011-08
ISBN-10: 1437983057
ISBN-13: 9781437983050

Prescription drug spending in the U.S. in 2009 totaled $250 billion, of which $78 billion -- or 31% -- was spent by the fed. govżt. Prescription drug spending by the fed. govżt., patients, and third-party payers, including employers, is driven by many factors, including the prices paid for drugs. This report: (1) examines U&C price trends for commonly used prescription drugs from 2006 through the first quarter of 2010 and compares these trends to those of other medical consumer goods and services; and (2) examines price trends using drug prices other than U&C. Also provides info. on the exte
14381

Author: Barbara D. Bovbjerg
Publisher: DIANE Publishing
Keywords: millions, applicants, individuals, applied, testimony, congressional, approve, continues, low, part, income, subsidy, ssa, medicare
Number of Pages: 20
Published: 2008-10
ISBN-10: 1437905927
ISBN-13: 9781437905922

To help the elderly and disabled with prescription drug costs, the Congress passed the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), which created a voluntary outpatient prescription drug benefit (Medicare Part D). A key element of the prescription drug benefit is the low-income subsidy, or żextra help,ż available to Medicare beneficiaries with limited income and resources to assist them in paying their premiums and other out-of-pocket costs. To assess the Social Security Adminżs. implementation of the subsidy, this report provides info. on: (1) the number of
3781

Author: Julie Somers
Publisher: DIANE Publishing
Keywords: prescription, drug, spending, medicares, drugs, using, generic, effects
Number of Pages: 36
Published: 2011-01
ISBN-10: 1437940390
ISBN-13: 9781437940398

This is a print on demand edition of a hard to find publication. Contents:(1) Overview of the Medicare Prescription Drug Benefit Program: Design of the Medicare Prescription Drug Benefit; Distribution of Spending in Medicare Part D; The Role of Private Plans in Medicare Part D; (2) Generic Drugs in Medicare Part D: Generic Substitution; Therapeutic Substitution; Comparing Potential Savings from Generic and Therapeutic Substitution; (3) Implications of Future Developments: First-Time Generic Entry; New Brand-Name Drugs; Biologics. (4) Appendix: Description of Data Used in This Analysis. Charts
4685

Author: David Austen
Publisher: DIANE Publishing
Keywords: drugs, prescription, market, evolving, pharmaceutical
Number of Pages: 18
Published: 2010-11
ISBN-10: 1437925057
ISBN-13: 9781437925050

Investment in R&D over the past several decades has produced many valuable new drug therapies that have made it possible to treat major illnesses that were not treated previously. Spending on prescription drugs became the fastest-growing category of total spending on health care in the U.S. Between 1994 and 2004, real spending on prescription drugs rose at an average annual rate of 11%, compared with 3% for hospital care and 4% for physicians¿ services. More recently, however, that growth has slowed. This report describes the current state of investment in drug R&D and the factors that influe
3563

Author: Marcia Crosse
Publisher: DIANE Publishing
Keywords: drug, marketing, counter, emergency, plan, unusual, over, contraceptive, application, decision, administration, process, deny, initial, food
Number of Pages: 66
Published: 2006-03-01
ISBN-10: 1422304434
ISBN-13: 9781422304433

In April 2003, Women's Capital Corp. submitted an application to the FDA requesting that the marketing status of its emergency contraceptive pill (ECP), Plan B, be switched from prescription to over-the-counter (OTC). ECPs can be used to prevent an unintended pregnancy when contraception fails or after unprotected intercourse, incl. cases of sexual assault. In May 2004, the FDA issued a not-approvableÓ letter for the switch application, citing safety concerns about the use of Plan B in women under 16 years of age without the supervision of a health care practitioner. Because the not-approvabl
17001
(Page 1 of 10)    First  
Previous
   Next   Last  Go to Page:
No Books found.